Sorafenib Tablet, Film Coated
Product Images NDC 51990-201

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sorafenib (NDC 51990-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Yabao Pharmaceutical Co., Ltd. Beijing, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fig1.jpg (Fig1)

A Kaplan-Meier survival curve chart showing the proportion of progression-free survival over time in months. The chart compares two groups: one treated with sorafenib (N=207) and a placebo group (N=210). The sorafenib group shows higher progression-free survival over the duration observed, with patient risk numbers indicated at select time points for both groups.*

FDA Label Image

Fig3.jpg (Fig3)

A Kaplan-Meier survival probability curve comparing sorafenib and placebo groups over 18 months from randomization. The graph shows survival probability percentage on the Y-axis and months from randomization on the X-axis. Sorafenib group (N=299) displays higher median survival (10.7 months) versus placebo (7.9 months). Patients at risk are listed below the graph for both groups at various time points.*

FDA Label Image

200 mg Label (Label 120s)

Label for sorafenib 200 mg film-coated tablets, USP. The label states that each tablet contains 200 mg sorafenib equivalent to 274 mg sorafenib tosylate. It indicates a prescription-only product with a quantity of 120 tablets, manufactured by Yabao Pharmaceutical Co., Ltd., Beijing. The label includes storage instructions and a barcode.*

FDA Label Image

200 mg Label (Label 60s)

Label for Sorafenib Tablets, USP 200 mg film-coated oral tablets by Yabao Pharmaceutical Co., Ltd., Beijing. The label indicates the prescription drug designation, package size of 60 tablets, storage instructions between 20°C and 25°C with allowances for excursions, and a barcode. The label includes dosage and storage information as per USP Controlled Room Temperature guidelines.*

FDA Label Image

Image Description (Logo)

FDA Label Image

Structural Formula (Structure)

Chemical structure of sorafenib, showing its molecular configuration with distinct aromatic rings, trifluoromethyl, chloro substituent, amide groups, and sulfonic acid moiety in the structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.